CAS: 1345982-69-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Linerixibat REF: TM-T3978CAS: 1345982-69-5 | 98.5% - 99.83% | 82.00 €~832.00 € | Tue 21 Jan 25 |
 | Linerixibat REF: 4Z-L-217001CAS: 1345982-69-5 | - - - | To inquire | Tue 21 Jan 25 |
 | Linerixibat REF: 3D-VDC98269CAS: 1345982-69-5 | Min. 95% | To inquire | Tue 25 Feb 25 |
 | GSK 2330672 REF: IN-DA009CBXCAS: 1345982-69-5 | 98% | - - - | Discontinued product |
Linerixibat
CAS:1345982-69-5
Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor. Linerixibat can lower glucose in an …
Formula:
C28H38N2O7S
Purity:
98.5% - 99.83%
Color and Shape:
Solid
Molecular weight:
546.68
Ref: TM-T3978
| 1mg | 82.00 € | ||
| 2mg | 115.00 € | ||
| 5mg | 207.00 € | ||
| 10mg | 348.00 € | ||
| 25mg | 588.00 € | ||
| 50mg | 832.00 € | ||
| 1mL*10mM (DMSO) | 252.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 4Z-L-217001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Linerixibat
CAS:1345982-69-5
Linerixibat is a drug that has been shown to reduce the accumulation of fat in …
Formula:
C28H38N2O7S
Purity:
Min. 95%
Molecular weight:
546.68 g/mol
Ref: 3D-VDC98269
| 10mg | 1,026.00 € | ||
| 25mg | 1,573.00 € | ||
| 50mg | 2,517.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
Ref: IN-DA009CBX
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
